76% of older adults think Medicare should cover obesity drugs
The vast majority of older adults - 83% - think health insurers should cover medications that can help people with obesity manage their...
top of page
Browse by category
Search
FDA approves ReShape Lifesciences’ next-generation Lap-Band 2.0 FLEX
The FDA has granted approval of a PMA supplement for ReShape Lifesciences’ next generation, enhanced Lap-Band 2.0 FLEX. According to the...
Journal Watch 13/12/2023
Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
USGI Medical completes Pilot Study of the POSE2.0 incisionless weight loss procedure
The FDA has acknowledged the successful completion of a pilot study of USGI Medical’s incisionless, endoscopic gastroplasty procedure,...
American Diabetes Association releases the Standards of Care in Diabetes - 2024
The American Diabetes Association (ADA) has released the ‘Standards of Care in Diabetes - 2024 (Standards of Care)’, a set of...
Prenatal exposure to GLP-1 receptor agonists may not pose greater risk than insulin
Infants born to women with pre-gestational type 2 diabetes who take second-line non-insulin antidiabetic medications (ADMs) during...
Lilly's Zepbound (tirzepatide) achieved total mean weight loss of 26.0% from baseline to 88 weeks
Detailed results from SURMOUNT-4 have shown Zepbound (tirzepatide) injection achieved superior mean percent change in body weight...
Skye to develop nimacimab for the treatment of obesity by targeting the endocannabinoid system
Skye Bioscience, a pharmaceutical company developing drugs targeting the endocannabinoid system (ECS), has announced that it plans to...
GLP-1-based pancreatic gene therapy maintained weight loss after semaglutide withdrawal in rodents
Fractyl Health has revealed that preclinical findings from its Rejuva gene therapy platform, presented at the World Congress Insulin...
GIP receptors profoundly impact metabolism and weight regulation
A preclinical study by Weill Cornell Medicine investigators has shown that a specific human genetic variant of a receptor that stimulates...
Browse by tag
bottom of page